Abstract

MotivationArtificial intelligence, trained via machine learning (e.g. neural nets, random forests) or computational statistical algorithms (e.g. support vector machines, ridge regression), holds much promise for the improvement of small-molecule drug discovery. However, small-molecule structure-activity data are high dimensional with low signal-to-noise ratios and proper validation of predictive methods is difficult. It is poorly understood which, if any, of the currently available machine learning algorithms will best predict new candidate drugs.ResultsThe quantile-activity bootstrap is proposed as a new model validation framework using quantile splits on the activity distribution function to construct training and testing sets. In addition, we propose two novel rank-based loss functions which penalize only the out-of-sample predicted ranks of high-activity molecules. The combination of these methods was used to assess the performance of neural nets, random forests, support vector machines (regression) and ridge regression applied to 25 diverse high-quality structure-activity datasets publicly available on ChEMBL. Model validation based on random partitioning of available data favours models that overfit and ‘memorize’ the training set, namely random forests and deep neural nets. Partitioning based on quantiles of the activity distribution correctly penalizes extrapolation of models onto structurally different molecules outside of the training data. Simpler, traditional statistical methods such as ridge regression can outperform state-of-the-art machine learning methods in this setting. In addition, our new rank-based loss functions give considerably different results from mean squared error highlighting the necessity to define model optimality with respect to the decision task at hand.Availability and implementationAll software and data are available as Jupyter notebooks found at https://github.com/owatson/QuantileBootstrap.Supplementary information Supplementary data are available at Bioinformatics online.

Highlights

  • Empirical methodologies guide a significant proportion of earlystage small-molecule drug discovery (Cumming et al, 2013; Keiser et al, 2007; Lipinski, 2004)

  • This work concerns the objective evaluation of the predictive ability of the latter, namely statistical and machine learning regression models trained on molecular structure-activity data

  • Use of regression modelling is often known as quantitative structure-activity relationship modelling (QSAR) (Sliwoski et al, 2014; Van De Waterbeemd and Gifford, 2003), and many different model classes have been used: support vector machines (Burbidge et al, 2001), ridge regression (Nandi et al, 2007), neural nets (Ajay et al, 1998; Lenselink et al, 2017; Nandi et al, 2007; Sadowski and Kubinyi, 1998) and random forests (Svetnik et al, 2003), to name but a few

Read more

Summary

Introduction

Empirical methodologies guide a significant proportion of earlystage small-molecule drug discovery (Cumming et al, 2013; Keiser et al, 2007; Lipinski, 2004). The goal of these models is to characterize the relationship between a highdimensional binary vector representation of small molecules (known as a molecular fingerprint) and the corresponding target specific in vitro activities In this context, use of regression modelling is often known as quantitative structure-activity relationship modelling (QSAR) (Sliwoski et al, 2014; Van De Waterbeemd and Gifford, 2003), and many different model classes have been used: support vector machines (Burbidge et al, 2001), ridge regression (Nandi et al, 2007), neural nets (Ajay et al, 1998; Lenselink et al, 2017; Nandi et al, 2007; Sadowski and Kubinyi, 1998) and random forests (Svetnik et al, 2003), to name but a few. The success of these models is in part due to high-throughput screening experiments which produce large structure-activity datasets (order of magnitude 102–106 datapoints)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call